Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Non-cash Items: 2022-2025

Historic Non-cash Items for Roivant Sciences (ROIV) over the last 3 years, with Jun 2025 value amounting to $113.0 million.

  • Roivant Sciences' Non-cash Items rose 7.94% to $113.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $113.0 million, marking a year-over-year increase of 7.94%. This contributed to the annual value of $110.7 million for FY2025, which is 77.84% down from last year.
  • Latest data reveals that Roivant Sciences reported Non-cash Items of $113.0 million as of Q2 2025, which was down 70.57% from $384.0 million recorded in Q1 2025.
  • Roivant Sciences' 5-year Non-cash Items high stood at $499.5 million for Q1 2024, and its period low was $1.9 million during Q1 2022.
  • In the last 3 years, Roivant Sciences' Non-cash Items had a median value of $107.6 million in 2024 and averaged $185.9 million.
  • In the last 5 years, Roivant Sciences' Non-cash Items soared by 14,653.61% in 2023 and then fell by 23.12% in 2025.
  • Quarterly analysis of 4 years shows Roivant Sciences' Non-cash Items stood at $55.6 million in 2022, then soared by 64.78% to $91.7 million in 2023, then rose by 17.24% to $107.5 million in 2024, then rose by 7.94% to $113.0 million in 2025.
  • Its Non-cash Items was $113.0 million in Q2 2025, compared to $384.0 million in Q1 2025 and $107.5 million in Q4 2024.